PEF is a newer treatment option for various cancers in the lungs that have failed first-line treatment. It can be offered for ...

Six-month results from U.S. clinical study show promise for the innovative technology in patients with stage IV non-small cell lung cancer or lung metastasis REDWOOD CITY, Calif., Nov. 11, 2025 ...

Surgery is a common treatment for non-small cell lung cancer (NSCLC), particularly when the disease is detected early and the tumor is small and is only in one part of the lung. For small cell lung ...

Precision-targeted radiation is proving a match for surgery in early-stage lung cancer, offering patients similar long-term survival with less invasiveness, and potentially transforming how this ...

Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer—the leading cause of cancer deaths worldwide—improved long-term survival overall compared with ...